Medicare Enrolled
Dr. Bassam Haddad, MD
Rheumatology · Westlake, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haddad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haddad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haddad
Dr. Bassam Haddad is a rheumatology specialist in Westlake, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Haddad performed 19,566 Medicare services across 1,892 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haddad received a total of $86,176 from 52 pharmaceutical and/or device companies across 1615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haddad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 19% volume in OH
$86,176 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,566
Medicare services
Top 19% in OH for rheumatology
1,892
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,151 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
10,200 | $11 | $37 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $18 | $30 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
525 | $1 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
516 | $82 | $190 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
226 | $8 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
224 | $10 | $18 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
207 | $11 | $40 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
201 | $8 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
193 | $60 | $135 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
169 | $5 | $10 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
167 | $3 | $6 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
164 | $1 | $12 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
111 | $51 | $131 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
107 | $47 | $180 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
98 | $18 | $27 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
79 | $95 | $251 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $109 | $250 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
44 | $13 | $19 |
| Rheumatoid factor analysis | 39 | $6 | $11 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $134 | $295 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
36 | $29 | $50 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
35 | $12 | $18 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
26 | $4 | $9 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $92 | $160 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
21 | $29 | $30 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
19 | $76 | $80 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $37 | $85 |
| X-ray of sacroiliac joint, 3 or more views An X-ray imaging test that takes three or more pictures of the joint connecting the lower spine to the hip bone. |
15 | $27 | $60 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
14 | $13 | $21 |
| Measurement of dna antibody, single stranded | 14 | $12 | $18 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
13 | $8 | $16 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
12 | $32 | $119 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.9% high complexity
34.7% medium
11.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$86,176
Total received (2018-2024)
Avg $12,311/year across 7 years
Top 8% in OH for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,615
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55,139 (64.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,348 (25.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,689 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,571
2023
$23,377
2022
$23,875
2021
$10,822
2020
$2,266
2019
$2,798
2018
$2,468
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$15,797
Amgen Inc.
$974
ABBVIE INC.
$899
Janssen Biotech, Inc.
$647
UCB, Inc.
$589
PFIZER INC.
$451
AstraZeneca Pharmaceuticals LP
$448
Boehringer Ingelheim Pharmaceuticals, Inc.
$150
E.R. Squibb & Sons, L.L.C.
$143
GlaxoSmithKline, LLC.
$122
Novartis Pharmaceuticals Corporation
$77
Radius Health, Inc.
$65
ANI Pharmaceuticals, Inc.
$55
Aurinia Pharma U.S., Inc.
$43
Mallinckrodt Hospital Products Inc.
$36
Actelion Pharmaceuticals US, Inc.
$27
Travere Therapeutics, Inc.
$17
SCILEX PHARMACEUTICALS INC.
$16
GENZYME CORPORATION
$15
Top 3 companies account for 85.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$55,183
Novartis Pharmaceuticals Corporation
$5,577
UCB, Inc.
$4,352
Amgen Inc.
$3,979
Janssen Biotech, Inc.
$3,812
PFIZER INC.
$1,947
AbbVie Inc.
$1,463
ABBVIE INC.
$1,459
AstraZeneca Pharmaceuticals LP
$1,277
E.R. Squibb & Sons, L.L.C.
$1,056
Genentech USA, Inc.
$966
Mallinckrodt Hospital Products Inc.
$765
GlaxoSmithKline, LLC.
$681
Horizon Therapeutics plc
$539
AbbVie, Inc.
$287
Regeneron Healthcare Solutions, Inc.
$275
Radius Health, Inc.
$269
Boehringer Ingelheim Pharmaceuticals, Inc.
$218
Alexion Pharmaceuticals, Inc.
$213
Actelion Pharmaceuticals US, Inc.
$199
Mallinckrodt Enterprises LLC
$193
Aurinia Pharma U.S., Inc.
$176
Mallinckrodt LLC
$145
Celgene Corporation
$137
Organon LLC
$90
GENZYME CORPORATION
$85
Antares Pharma, Inc.
$80
Travere Therapeutics, Inc.
$62
Calliditas Therapeutics US Inc.
$59
MEDEXUS PHARMA, INC.
$57
Horizon Pharma plc
$57
PAINTEQ LLC
$56
ANI Pharmaceuticals, Inc.
$55
Hikma Pharmaceuticals USA
$47
Daiichi Sankyo Inc.
$40
SOBI, INC
$30
Sobi, Inc
$25
DePuy Synthes Sales Inc.
$25
MEDAC PHARMA, INC.
$25
West-Ward Pharmaceuticals
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
Mylan Institutional Inc.
$20
Gilead Sciences, Inc.
$17
Ultragenyx Pharmaceutical Inc.
$17
SCILEX PHARMACEUTICALS INC.
$16
Sebela Pharmaceuticals Inc.
$16
Janssen Pharmaceuticals, Inc
$15
Novo Nordisk Inc
$15
Exeltis, USA Inc.
$14
Fresenius Kabi USA, LLC
$14
ARBOR PHARMACEUTICALS, INC.
$14
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 75.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Adempas · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · FARXIGA · FLUMIST QUADRIVALENT · FORTEO · HUMIRA · Horizant · Hulio · Humira · ILARIS · INFLECTRA · INJECTAFER · JARDIANCE · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · Otrexup · PAINTEQ · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TARPEYO · TAVNEOS · TREMFYA · Tavneos · Tymlos · UBRELVY · UPTRAVI · VELSIPITY · XARELTO · XELJANZ · XYOSTED · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in OH.
Geographic Context
Rheumatologists within 10 mi
48
Per 100K population
3.8
County median income
$62,823
Nearest hospital
UH ST JOHN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haddad is a mixed practice specialist, with above-average Medicare volume (top 19% in OH), with speaking/promotional industry engagement in the top 8% of OH peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haddad experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Haddad performed 10,200 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haddad receive payments from pharmaceutical companies?
Yes. Dr. Haddad received a total of $86,176 from 52 companies across 1,615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haddad's costs compare to other rheumatologists in Westlake?
Dr. Haddad's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haddad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Westlake
Browse rheumatologists in Westlake ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in OH
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in OH
Which OH rheumatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology